anmelden
OMX Nordic 40
2.675,22
PKT
-10,35
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.12.17 | ABB (Asea Brown Boveri) kaufen | Kepler Cheuvreux | |
| 12.12.17 | Nokia overweight | JP Morgan Chase & Co. | |
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 12.12.17 | Volvo (B) Neutral | UBS AG | |
| 12.12.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 11.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 07.12.17 | Novo Nordisk Reduce | HSBC | |
| 06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.12.17 | Fortum Sell | Deutsche Bank AG | |
| 06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 05.12.17 | AstraZeneca buy | Deutsche Bank AG | |
| 04.12.17 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 02.12.17 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 01.12.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 01.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 30.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 30.11.17 | Nokia Neutral | BNP PARIBAS | |
| 29.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.11.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 28.11.17 | Novo Nordisk buy | UBS AG | |
| 24.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 22.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 22.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.11.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.11.17 | AstraZeneca Reduce | HSBC | |
| 15.11.17 | Novo Nordisk Underweight | Barclays Capital | |
| 14.11.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 10.11.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 10.11.17 | AstraZeneca Hold | S&P Capital IQ | |
| 09.11.17 | AstraZeneca Neutral | UBS AG | |
| 08.11.17 | Nokia Neutral | BNP PARIBAS | |
| 08.11.17 | AstraZeneca buy | Citigroup Corp. |
